|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang J, Yu H, Zhang Y, Zhang X, Zheng G,
Gao Y, Wang C and Zhou L: A functional TNFAIP2 3′-UTR rs8126
genetic polymorphism contributes to risk of esophageal squamous
cell carcinoma. PLoS One. 9:e1093182014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
He Y, Mingyan E, Wang C, Liu G, Shi M and
Liu S: CircVRK1 regulates tumor progression and radioresistance in
esophageal squamous cell carcinoma by regulating
miR-624-3p/PTEN/PI3K/AKT signaling pathway. Int J Biol Macromol.
125:116–123. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhu Y, Ma Y, Peng H, Gong L, Xiao M, Xiang
L, He D and Cao K: MiR-130b promotes the progression of oesophageal
squamous cell carcinoma by targeting SASH1. J Cell Mol Med.
23:93–103. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yu X, Li W, Xia Z, Xie L, Ma X, Liang Q,
Liu L, Wang J, Zhou X, Yang Y and Liu H: Targeting MCL-1 sensitizes
human esophageal squamous cell carcinoma cells to cisplatin-induced
apoptosis. BMC Cancer. 17:4492017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hua Y, Zhao K, Tao G, Dai C and Su Y:
MiR-25 promotes metastasis via targeting FBXW7 in esophageal
squamous cell carcinoma. Oncol Rep. 38:3030–3038. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Al-Rugeebah A, Alanazi M and Parine NR:
MEG3: An oncogenic long non-coding RNA in different cancers. Pathol
Oncol Res. 25:859–874. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhao M, Wang J, Xi X, Tan N and Zhang L:
SNHG12 promotes angiogenesis following ischemic stroke via
regulating miR-150/VEGF pathway. Neuroscience. 390:231–240. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bo H, Fan L, Gong Z, Liu Z, Shi L, Guo C,
Li X, Liao Q, Zhang W, Zhou M, et al: Upregulation and
hypomethylation of lncRNA AFAP1AS1 predicts a poor prognosis and
promotes the migration and invasion of cervical cancer. Oncol Rep.
41:2431–2439. 2019.PubMed/NCBI
|
|
12
|
Lv D, Sun R, Yu Q and Zhang X: The long
non-coding RNA maternally expressed gene 3 activates p53 and is
downregulated in esophageal squamous cell cancer. Tumour Biol.
2016.(Epub ahead of print). View Article : Google Scholar
|
|
13
|
Xu Y, Qiu M, Chen Y, Wang J, Xia W, Mao Q,
Yang L, Li M, Jiang F, Xu L and Yin R: Long noncoding RNA, tissue
differentiation-inducing nonprotein coding RNA is upregulated and
promotes development of esophageal squamous cell carcinoma. Dis
Esophagus. 29:950–958. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Huang ZL, Chen RP, Zhou XT, Zhan HL, Hu
MM, Liu B, Wu GD and Wu LF: Long non-coding RNA MEG3 induces cell
apoptosis in esophageal cancer through endoplasmic reticulum
stress. Oncol Rep. 37:3093–3099. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xu G, Zhang Y, Li N, Zhang JB and Xu R:
LncRNA CCHE1 in the proliferation and apoptosis of gastric cancer
cells. Eur Rev Med Pharmacol Sci. 22:2631–2637. 2018.PubMed/NCBI
|
|
16
|
Liao Y, Cheng S, Xiang J and Luo C: lncRNA
CCHE1 increased proliferation, metastasis and invasion of non-small
lung cancer cells and predicted poor survival in non-small lung
cancer patients. Eur Rev Med Pharmacol Sci. 22:1686–1692.
2018.PubMed/NCBI
|
|
17
|
Peng W and Fan H: Long noncoding RNA CCHE1
indicates a poor prognosis of hepatocellular carcinoma and promotes
carcinogenesis via activation of the ERK/MAPK pathway. Biomed
Pharmacother. 83:450–455. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhan Y, Li Y, Guan B, Chen X, Chen Z, He
A, He S, Gong Y, Peng D, Liu Y, et al: Increased expression of long
non-coding RNA CCEPR is associated with poor prognosis and promotes
tumorigenesis in urothelial bladder carcinoma. Oncotarget.
8:44326–44334. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen Y, Wang CX, Sun XX, Wang C, Liu TF
and Wang DJ: Long non-coding RNA CCHE1 overexpression predicts a
poor prognosis for cervical cancer. Eur Rev Med Pharmacol Sci.
21:479–483. 2017.PubMed/NCBI
|
|
20
|
Gaballah HH, Gaber RA, Elrashidy MA,
Elshahat DA, Hablus MA and Ebeid AM: Expression of long non-coding
RNA CCHE1 in colorectal carcinoma: Correlations with
clinicopathological features and ERK/COX-2 pathway. Mol Biol Rep.
46:657–667. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang S, Liang Y, Wu Y, Chen X, Wang K, Li
J, Guan X, Xiong G, Yang K and Bai Y: Upregulation of a novel
lncRNA LINC01980 promotes tumor growth of esophageal squamous cell
carcinoma. Biochem Biophys Res Commun. 513:73–80. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dong Z, Liang X, Wu X, Kang X, Guo Y, Shen
S, Liang J and Guo W: Promoter hypermethylation-mediated
downregulation of tumor suppressor gene SEMA3B and lncRNA
SEMA3B-AS1 correlates with progression and prognosis of esophageal
squamous cell carcinoma. Clin Exp Metastasis. 36:225–241. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cui Z, Luo Z, Lin Z, Shi L, Hong Y and Yan
C: Long non-coding RNA TTN-AS1 facilitates tumorigenesis of
papillary thyroid cancer through modulating miR-153-3p/ZNRF2 axis.
J Gene Med. 21:e30832019. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang ZW, Chen JJ, Xia SH, Zhao H, Yang
JB, Zhang H, He B, Jiao J, Zhan BT and Sun CC: Long intergenic
non-protein coding RNA 319 aggravates lung adenocarcinoma
carcinogenesis by modulating miR-450b-5p/EZH2. Gene. 650:60–67.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang Y, Li R, Ding X, Zhang K and Qin W:
Upregulation of long non-coding RNA SNHG6 promote esophageal
squamous cell carcinoma cell malignancy and its diagnostic value.
Am J Transl Res. 11:1084–1091. 2019.PubMed/NCBI
|
|
27
|
Zhang C, Jiang F, Su C, Xie P and Xu L:
Upregulation of long noncoding RNA SNHG20 promotes cell growth and
metastasis in esophageal squamous cell carcinoma via modulating
ATM-JAK-PD-L1 pathway. J Cell Biochem. 2019.(Epub ahead of
print).
|
|
28
|
Dahal U, Kang L and Gupta M: RNA m6A
methyltransferase METTL3 regulates invasiveness of melanoma cells
by matrix metallopeptidase 2. Melanoma Res. 29:382–389. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen W, Zhong X, Wei Y, Liu Y, Yi Q, Zhang
G, He L, Chen F, Liu Y and Luo J: Retraction note to: TGF-β
regulates survivin to affect cell cycle and the expression of EGFR
and MMP9 in glioblastoma. Mol Neurobiol. 54:75512017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Singh M, Yelle N, Venugopal C and Singh
SK: EMT: Mechanisms and therapeutic implications. Pharmacol Ther.
182:80–94. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xia XL, Xue D, Xiang TH, Xu HY, Song DK,
Cheng PG and Wang JQ: Overexpression of long non-coding RNA CRNDE
facilitates epithelial-mesenchymal transition and correlates with
poor prognosis in intrahepatic cholangiocarcinoma. Oncol Lett.
15:4105–4112. 2018.PubMed/NCBI
|
|
32
|
Hua W, Zhao Y, Jin X, Yu D, He J, Xie D
and Duan P: METTL3 promotes ovarian carcinoma growth and invasion
through the regulation of AXL translation and epithelial to
mesenchymal transition. Gynecol Oncol. 151:356–365. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liang R, Xiao G, Wang M, Li X, Li Y, Hui
Z, Sun X, Qin S, Zhang B, Du N, et al: SNHG6 functions as a
competing endogenous RNA to regulate E2F7 expression by sponging
miR-26a-5p in lung adenocarcinoma. Biomed Pharmacother.
107:1434–1446. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yang W, Shan Z, Zhou X, Peng L, Zhi C,
Chai J, Liu H, Yang J and Zhang Z: Knockdown of lncRNA GHET1
inhibits osteosarcoma cells proliferation, invasion, migration and
EMT in vitro and in vivo. Cancer Biomark. 23:589–601. 2018.
View Article : Google Scholar : PubMed/NCBI
|
